semaglutide tirzepatide vs. Semaglutide: Which Weight Loss Medication Is Right for You? Semaglutide vs. Tirzepatide for weight

While many people experience positive results, side effects are possible

doi: 10.1016/S0140-6736(17)32129-3

A clinically relevant effect will depend on the extent of PK changes and the therapeutic index of the co-administered oral drug

Long-term outcomes over 6 to 12 months show average total weight loss of 10 to 15 percent of body weight in clinical trials, with some patients losing 20 to 22 percent

An ongoing interventional, single-arm, open-label trial (Dapagut study, NCT05965440) is evaluating the effects of dapagliflozin on gut microbiota composition and microbiota-derived metabolites over 12 weeks in non-diabetic adults with CKD